Skip to main content
Diagnostic Medical Systems logo

Diagnostic Medical Systems — Investor Relations & Filings

Ticker · ALDMS ISIN · FR0012202497 LEI · 969500RKTIGCNNIKIN19 PA Manufacturing
Open in API
Filings indexed 230 across all filing types
Latest filing 2025-04-14 Earnings Release
Country FR France
Listing PA ALDMS

About Diagnostic Medical Systems

https://www.dms.com/en/home/

Diagnostic Medical Systems (DMS) specializes in the development, design, and manufacturing of medical imaging systems. The company's core focus is on digital radiology and bone densitometry. Its product portfolio includes radiography and fluoroscopy systems, mobile x-ray units, surgical C-arms, and bone densitometers. DMS is engaged in developing next-generation imaging solutions aimed at improving patient care and personalized medicine. Key development projects include new mobile and surgical imaging equipment and an advanced range of bone densitometers for diagnosing and monitoring pathologies affecting bone mineral density.

Recent filings

Filing Released Lang Actions
DMS Group: ANNUAL RESULTS 2024 - SUSTAINED GROWTH SIGNIFICANT IMPROVEMENT OF OPERATIONAL PROFITABILITY - CONFIRMATION OF THE IMAGING 2027 PLAN
Earnings Release Classification · 95% confidence The document is explicitly titled "PRESS RELEASE • DMS Group Annual Results 2024" and contains detailed financial tables for the year 2024, including Revenue, EBITDA, Operating Income, and Net Result, comparing them to 2023. It discusses the full fiscal year performance and confirms the long-term strategic plan (#Imaging 2027 Plan). This content strongly indicates a full-year financial disclosure. Although it mentions the 'Annual Report' is available elsewhere, the document itself is the primary announcement of these annual results, which aligns best with the 'Earnings Release' (ER) category, as it is a press release summarizing the full-year performance. However, given the depth of the financial data and the reference to the 'Annual Results 2024', it is more comprehensive than a typical quarterly earnings release (ER). Since it covers the full year and contains detailed financial figures, it is most closely related to the Annual Report (10-K) content, but presented as a press release summary. In many contexts, the press release summarizing the 10-K data is classified as an Earnings Release (ER). Given the comprehensive nature covering the entire year, and the fact that it is a formal announcement of the 'Annual Results', ER is the most appropriate fit among the provided options for a results announcement document that is not the formal 10-K filing itself. If 'Annual Results Press Release' were an option, it would be ideal, but ER serves as the best proxy for a major periodic results announcement. FY 2024
2025-04-14 English
DMS Group : Organisation d'une visioconférence destinée aux actionnaires et investisseurs individuels
Report Publication Announcement Classification · 99% confidence The document is a press release announcing an upcoming videoconference for shareholders and individual investors scheduled for April 22, 2025. The purpose of this conference is to present the 2024 results, Q1 2025 revenue, and strategy, allowing for Q&A with management. This announcement itself is not the full earnings release (ER) or the comprehensive interim report (IR), but rather an announcement about an event where financial information (results and revenue updates) will be discussed. Since the document is short and primarily serves to invite participation in an event where results will be discussed, it fits best as an announcement related to investor communication or a general regulatory filing. Given the options, it is an announcement about an upcoming event where financial results will be discussed, which is often categorized under general investor relations communication. However, the core content is the scheduling of a call to discuss results (2024 results and Q1 2025 revenue). If this were the transcript, it would be CT. If it were the full results, it would be ER or IR. Since it is an announcement *about* a call where results will be presented, and it includes a forward-looking calendar of future financial updates, it is most closely related to investor communication surrounding earnings/results. Because it is an announcement of a future event where results will be discussed, and not the results themselves, it is not a standard ER or IR. It is an announcement of a meeting, which often falls under general regulatory announcements (RNS) or, if it were a proxy/meeting notice, DEF 14A or AGM-R. Since it is a general investor call, RNS is the most appropriate fallback if a specific 'Investor Event Announcement' code doesn't exist. However, the content strongly relates to the discussion of financial results (2024 results and Q1 2025 revenue). If we interpret this as a notice about an event where financial performance is the main topic, it is a form of investor communication. Given the options, and the fact that it is a press release announcing a call to discuss results, RNS (Regulatory Filings/General Announcement) is the safest classification, as it is not the result itself, nor a proxy statement, nor a transcript.
2025-04-11 French
DMS Group Selected by Ukrainian Authorities for the Delivery of 120 Emergency Mobile Radiology Units in a Contract Worth EUR 11M
Regulatory Filings Classification · 100% confidence The document is a press release dated March 7, 2025, announcing a significant contract win (€11M) by DMS Group with Ukrainian authorities for delivering mobile radiology units. It details the contract scope, financing source (French Economic Resilience Fund), and includes quotes from the CEO and mentions government officials. This type of announcement, detailing a major business development, contract award, or strategic partnership, does not fit the specific definitions for 10-K, IR, ER, or AGM materials. It is a general corporate announcement regarding business operations and strategy, which is best classified as a Regulatory Filing (RNS) as it is a public disclosure of material information that doesn't fit a more specific category like CAP (Financing) or TAR (M&A). Given its nature as a press release announcing a major contract, RNS is the most appropriate general regulatory disclosure category.
2025-03-07 English
Le Groupe DMS, sélectionné par les autorités ukrainiennes pour la livraison de 120 mobiles de radiologie d'urgence, pour un contrat de 11 M EUR
Regulatory Filings Classification · 100% confidence The document is titled 'COMMUNIQUÉ DE PRESSE' (Press Release) and announces a significant contract win (120 mobile radiology units for Ukraine worth 11 M€) with specific financial details and future timelines (Q2/Q3 2025). This format, focusing on a major business event, contract award, or significant operational update, aligns best with a general regulatory announcement or press release that doesn't fit a more specific financial report category (like 10-K, ER, or IR). Since it is a formal announcement of a business event, it is classified as a Regulatory Filing (RNS) as the most appropriate general category, although 'CAP' (Capital/Financing Update) might be considered if the focus was purely on the funding mechanism, but here the focus is the contract award itself. Given the options, RNS serves as the best catch-all for significant, non-standardized corporate news releases.
2025-03-07 French
DMS GROUP PRÉSENTE SES INNOVATIONS MAJEURES AU CONGRÈS EUROPÉEN DE RADIOLOGIE (ECR) 2025
Regulatory Filings Classification · 100% confidence The document is a press release dated February 25, 2025, announcing that DMS Group will present its innovations at the European Congress of Radiology (ECR) 2025. It details specific products (Stratos DR, M1 in ADAM version, Platinum, ADAM C, Onyx) and mentions an upcoming symposium. This type of announcement, detailing participation in an industry event and showcasing new products/technologies, is characteristic of a general corporate update or news release, rather than a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR). Since it is a general announcement of corporate activity and product focus, and does not fit the specific categories like M&A (TAR), Director's Dealing (DIRS), or Dividend (DIV), the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory or significant corporate news announcements that aren't covered by more specific codes.
2025-02-25 French
DMS GROUP PRESENTS ITS MAJOR INNOVATIONS AT THE 2025 EUROPEAN CONGRESS OF RADIOLOGY (ECR)
Regulatory Filings Classification · 100% confidence The document is a press release dated February 25, 2025, announcing DMS Group's participation and presentation of major innovations at the 2025 European Congress of Radiology (ECR). It details specific products being showcased and mentions an upcoming symposium. This type of announcement, focusing on participation in an industry event and product promotion rather than mandatory financial reporting (like 10-K, ER, IR) or corporate governance changes (like MANG, DIRS), fits best under a general regulatory announcement or news release category. Since there is no specific category for 'Event Participation Announcement' and it is not a formal financial filing, it defaults to the general Regulatory Filings category (RNS) as a significant corporate news item.
2025-02-25 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.